Keros Therapeutics Inc (KROS) valuation · rev $243.9M
Keros Therapeutics Inc (KROS) rev $243.9M.
| Metric | Value |
|---|---|
| Market cap | $208.8M |
| Revenue | $243.9M |
| P/S | 0.9 |
KROS valuation FAQ
What is KROS's market cap?
Keros Therapeutics Inc (KROS) market cap is $208.8M on the latest cached fundamentals snapshot.
What is KROS's latest revenue?
Latest cached Keros Therapeutics Inc (KROS) revenue was $243.9M. Statements: https://lician.com/financials/kros
What is KROS's price-to-sales ratio?
Keros Therapeutics Inc (KROS) price-to-sales (P/S) is 0.9, cached market cap $208.8M divided by revenue $243.9M.
How many KROS valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Keros Therapeutics Inc (KROS): Market cap, Revenue, and P/S.
Where is KROS valuation listed?
Cached valuation multiples for Keros Therapeutics Inc (KROS) are listed at https://lician.com/valuation/kros.
Not investment advice. Cached rows, not a live tape.